Sports
AHA conference news: Novo Nordisk's ZEUS trial failure examined “These results, the fact that they're negative, does not invalidate that inflammation plays a very important role in cardiovascular disease.".
“These results, the fact that they're negative, does not invalidate that inflammation plays a very important role in cardiovascular disease.".
Dr. Kai NakamuraChief Science CorrespondentPublished Nov 7, 2026 at 11:07 AM EST · 1 min read
AHA conference news: Novo Nordisk's ZEUS trial failure examined “These results, the fact that they're negative, does not invalidate that inflammation plays a very important role in cardiovascular disease.". “These results, the fact that they're negative, does not invalidate that inflammation plays a very important role in cardiovascular disease.".
Continue reading
Latest →Corrections, sourcing and article labels are part of the publication record. See our editorial standards.